Systematic review of 13 studies (6 RCTs, N=310, meta-analysed) in depressive disorders with suicidality: accelerated TMS showed no significant advantage over sham or standard TMS for post-treatment suicidality (SMD 0.17, 95% CI −0.62 to 0.95); adverse effects were more frequent.
Meta-analysisn = 625
Joseph et al. Efficacy and safety of accelerated transcranial magnetic stimulation on suicidality in depressive disorders: A systematic review and meta-analysis